Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

NCT06103669 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT06103669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06103669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)
Lead sponsor
University of California, Davis
Phase
Not applicable
Overall status
Recruiting
Start date
October 5, 2023
Completion date
December 31, 2033
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, head and neck cancer, oligoprogressive, other cancer, sarcoma